Delivery Order SPE2DB20D9331-SPE2DB25FL2C0
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Altafluor Benox 0.25%-0.4% drops in a 5 mL container. The delivery order, valued at $1,014.00, was issued on August 8, 2025, with an ultimate completion date of August 11, 2025. This award represents a firm fixed-price contract with no set-aside designation, issued under the company's existing...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,014.24 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Altafluor Benox 0.25%-0.4% eye drops in 5 milliliter vials, with a period of performance through November 1, 2024. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA,...
- This is a firm fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $1,014.00, was awarded on June 7, 2023, by the Defense Logistics Agency (DLA) for the supply of a pharmaceutical product, Altafluor Benox 0.25%-0.4% Ophthalmic Drops, 5 ml. The contract has an ultimate completion date of June 8, 2023. DMS Pharmaceutical Group is a key supplier of a wide range of pharmaceutical products...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,690.40 contract is for the delivery of Altafluor Benox 0.25%-0.4% Drops 5ml, a specialized pharmaceutical product, with a completion date of March 17, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
- This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, awarded by the Defense Logistics Agency (DLA), is a delivery order valued at $1,014.24 for the supply of ALTAFLUOR BENOX 0.25%-0.4% DRP 5ML. The contract has an ultimate completion date of April 29, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order, valued at $1,521.36, is for the supply of ALTAFLUOR BENOX 0.25%-0.4% DRP 5ML, a pharmaceutical product, with a completion date of February 23, 2024. DMS Pharmaceutical Group Inc. holds a single-award indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $1,267.80 and covers the delivery of ALTAFLUOR BENOX 0.25%-0.4% DRP 5ML, a specialized pharmaceutical product, with a completion date of February 3, 2025. DMS Pharmaceutical Group Inc. is a significant supplier to the Department of Defense (DoD), holding a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,014.24 firm fixed-price delivery order is for the supply of an ophthalmic drug, Altafluor Benox 0.25%-0.4% Eye Drops, 5 mL, to support the medical supply needs of the Department of Defense (DoD). This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS...
- This is a firm fixed-price delivery order worth $1,628.16 awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for 4554872601 - ALTAFLUOR BENOX 0.25%-0.4% DRP 5ML, with a completion date of September 22, 2021. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,679.96 by the Defense Logistics Agency on September 2, 2025, with completion targeted for September 3, 2025. This delivery order, which carries no set-aside designation, falls under the company's larger $499.999 billion Indefinite Delivery Contract with DLA's SPE2DB program, valid through November 2026. The delivery...
- SPE2DB20D9331Indefinite Delivery Contract
- SPE2DB20D9331-SPE2DB25FL2C0Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $1,680 firm fixed-price delivery order by the Defense Logistics Agency on September 26, 2025, for the supply of Altafluor Benox 0.25%-0.4% drops in 5ml units. The award carries an ultimate completion date of September 29, 2025, and includes no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499,999,999 vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting medical supply needs across Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing contracts for branded and generic prescription drugs, biologics, and medical consumables distributed to military health facilities. The company's extensive contract portfolio with the DLA demonstrates its capability to deliver specialized pharmaceutical products ranging from oncology treatments to vaccines and medical devices. This particular delivery order for ophthalmic medication reflects the contractor's role in supporting the Defense Logistics Agency's mission to maintain adequate pharmaceutical inventory and medical supply availability for DoD healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/26/25 |